Item 1.01 Entry into a Material Definitive Agreement. | ||||||||
| Item 9.01 Financial Statements and Exhibits. | ||||||||
| SIGNATURES | ||||||||
| Exhibit Index | ||||||||
| EXHIBIT 10.1 | ||||||||
Table of Contents
Item 1.01 Entry into a Material Definitive Agreement.
On December 29, 2006, StemCells, Inc. (the “Company”) entered into a Sales Agreement (the
“Agreement”) with Cantor Fitzgerald & Co. (“Cantor”) for the purpose of selling shares of the
Company’s common stock in at-the-market offerings or negotiated transactions from time to time. The
Company may offer up to 10,000,000 shares of its common stock pursuant to the Agreement. Cantor
will be paid compensation equal to 5.0% of the gross proceeds from the sales of common stock
pursuant to the terms of the Agreement.
A copy of the Agreement is attached as Exhibit 10.1 to this Current Report and is incorporated
herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
10.1 Sales Agreement between StemCells, Inc. and Cantor Fitzgerald & Co. dated December 29, 2006
